CA2161737C - Gel de metronidazole - Google Patents

Gel de metronidazole

Info

Publication number
CA2161737C
CA2161737C CA002161737A CA2161737A CA2161737C CA 2161737 C CA2161737 C CA 2161737C CA 002161737 A CA002161737 A CA 002161737A CA 2161737 A CA2161737 A CA 2161737A CA 2161737 C CA2161737 C CA 2161737C
Authority
CA
Canada
Prior art keywords
composition
effective amount
metronidazole
amount
sunscreen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002161737A
Other languages
English (en)
Other versions
CA2161737A1 (fr
Inventor
Richard J. Mackay
Jacques D. Bourgeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Canada Inc
Original Assignee
Stiefel Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Canada Inc filed Critical Stiefel Canada Inc
Priority to CA002161737A priority Critical patent/CA2161737C/fr
Publication of CA2161737A1 publication Critical patent/CA2161737A1/fr
Application granted granted Critical
Publication of CA2161737C publication Critical patent/CA2161737C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002161737A 1995-10-30 1995-10-30 Gel de metronidazole Expired - Lifetime CA2161737C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002161737A CA2161737C (fr) 1995-10-30 1995-10-30 Gel de metronidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002161737A CA2161737C (fr) 1995-10-30 1995-10-30 Gel de metronidazole

Publications (2)

Publication Number Publication Date
CA2161737A1 CA2161737A1 (fr) 1997-05-01
CA2161737C true CA2161737C (fr) 1998-10-20

Family

ID=4156874

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002161737A Expired - Lifetime CA2161737C (fr) 1995-10-30 1995-10-30 Gel de metronidazole

Country Status (1)

Country Link
CA (1) CA2161737C (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1206937B1 (fr) * 1999-07-16 2008-01-23 Shoei Co., Ltd. Preparations de nitroimidazole a usage externe pour traiter la dermatite atopique
US20020192272A1 (en) * 2001-03-28 2002-12-19 Popp Karl F. Metronidazole pledgets
US7357938B2 (en) 2001-07-09 2008-04-15 Stiefel Laboratories, Inc. Sulfacetamide formulations for treatment of rosacea
US8501202B2 (en) 2001-07-09 2013-08-06 Aqua Pharmaceuticals, Llc Sulfacetamide formulations for treatment of skin dermatoses
DE102004004969A1 (de) * 2004-01-28 2005-08-18 Beiersdorf Ag Verwendung von UV-Lichtschutzfiltern in Anti-Akne-Zubereitungen
FR2866568B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter un desordre de la vascularisation cutanee
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
WO2012138928A1 (fr) * 2011-04-06 2012-10-11 Lancell, L.L.C. Procédé pour identifier une nouvelle classe d'adjuvants immunologiques

Also Published As

Publication number Publication date
CA2161737A1 (fr) 1997-05-01

Similar Documents

Publication Publication Date Title
US10881640B2 (en) Topical pharmaceutical compositions for treatment of pilonidal sinus wounds
EP1051193B1 (fr) Preparations topiques anhydres pour la peau comprenant du ketoconazole
CA1334280C (fr) Gels aqueux contenant des medicaments topiques
US8735393B2 (en) Anhydrous topical skin preparations
AU632655B2 (en) Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
AU621589B2 (en) Topical metronidazole formulations and therapeutic uses thereof
EP0954278B1 (fr) Compositions pharmaceutiques contenant de l'huile de noix de kukui
CN1547475B (zh) 含电子转移试剂的磷酸酯衍生物的皮肤制剂
JPH04124134A (ja) 抗真菌性ゲル配合物
US5098717A (en) Method of treatment for pruritus
EP0513832A1 (fr) Utilisation du dibutyle d'adipate et du myristate d'isopropyle dans des produits à usage topique au transdermal
AU2009223158A1 (en) Formulations of vitamin K analogs for topical use
JP2001504137A (ja) 新規抗微生物性化粧用組成物
CA2161737C (fr) Gel de metronidazole
JP2002536313A (ja) 角質層機能の増強のための硫酸コレステロール組成物
Lesher Jr et al. Antifungal agents in dermatology
US5208015A (en) Topical anti-fungal agents having anti-inflammatory activity
US20070275093A1 (en) Methods for Treating Non-Microbial Inflammatory Skin Conditioners
EP1159956B1 (fr) Préparations anhydres topiques pour la peau
JP2000143518A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20151030